Dengue Reemergence: The Challenges Ahead

Amos Watentena; Ikem Chris Okoye; Ikechukwu Eugene Onah

doi:10.21467/ias.9.1.132-140

Authors

Amos Watentena Department of Zoology and Environmental Biology, University of Nigeria
Ikem Chris Okoye Department of Zoology and Environmental Biology, University of Nigeria
Ikechukwu Eugene Onah Department of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria,Nsukka

DOI:

https://doi.org/10.21467/ias.9.1.132-140

Abstract

The global expansion of competent Dengue vectors in tropical and sub-tropical areas, and the favorable conditions for disease transmission demonstrates a critical public health challenge ahead. This review provides an insight into some key underlying gaps while attempting to suggest alternatives towards the containment and hence eradication of Dengue. The non-existence of an efficient vaccine against all DENV serotypes and the rapid global emergence of COVID-19, are undermining the complexities of vaccine development and disrupting global health efforts for the management of Dengue respectively. The development of sustainable DENV control programs now requires a multifaceted approach involving the integration of the recently developed multi-platforms application in entomological surveillance, community awareness, modelling, vaccination, vector control, and also ensuring that Dengue control efforts are not hampered or neglected during COVID-19 pandemic. This approach requires active collaboration and communication of scientists from various disciplines, economic support from funding agencies and institutions as well as support from the communities, governments and public health organizations.

Keywords:

Dengue, DENV, Aedes aegypti, Aedes albopictus, vaccines, vector control

Downloads

Download data is not yet available.

References

G. Rezza, “Aedes albopictus and the reemergence of dengue,” BMC Public Health, vol. 12, no. 1, pp. 2–4, 2012.

M. Kashif Zahoor et al., Dengue fever: a general perspective. IntechOpen, 2019.

G. M. Vazquez-Prokopec, “Dengue control: the challenge ahead,” Future Microbiol., vol. 6, no. 3, pp. 251–253, 2011.

L. M. Schwartz, M. E. Halloran, A. P. Durbin, and I. M. Longini, “The dengue vaccine pipeline: implications for the future of dengue control,” Vaccine, vol. 33, no. 29, pp. 3293–3298, 2015.

M. S. Diamond and T. C. Pierson, “Molecular insight into dengue virus pathogenesis and its implications for disease control,” Cell, vol. 162, no. 3, pp. 488–492, 2015.

D. J. Gubler, “Dengue and dengue hemorrhagic fever,” Clin. Microbiol. Rev., vol. 11, no. 3, pp. 480–496, 1998.

D. J. Gubler, “Dengue and dengue hemorrhagic fever,” in Tropical Infectious Diseases, vol. 17, no. 4, 2011, p. 813.

U. C. Chaturvedi and R. Nagar, “Dengue and dengue haemorrhagic fever: Indian perspective,” J. Biosci., vol. 33, no. 4, pp. 429–441, 2008.

W. Fan, S. Yu, and T. M. Cosgriff, “The re-emergence of dengue in China,” Rev. Infect. Dis., vol. 2, no. Supl 4, 1989.

T. Takasaki, “Imported dengue fever/dengue hemorrhagic fever cases in Japan,” Trop. Med. Health, vol. 39, no. 4, pp. 13–15, 2011.

D. J. Gubler and G. G. Clark, “Dengue hemorrhagic fever.,” Emerg. Infect. Dis., vol. 1, no. 2, pp. 55–57, 1995.

D. J. Gubler and G. G. Clark, “Dengue/dengue hemorrhagic fever: the emergence of a global health problem,” Emerg. Infect. Dis., vol. 1, no. 2, pp. 55–57, 2008.

A. H. Fagbami and A. B. Onoja, “Dengue haemorrhagic fever: an emerging disease in Nigeria, West Africa,” J. Infect. Public Health, vol. 11, no. 6, pp. 757–762, 2018.

A. B. Onoja, J. A. Adeniji, and O. D. Olaleye, “High rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria,” Acta Trop., vol. 160, pp. 39–43, 2016.

F. Were, “The dengue situation in Africa,” Paediatr. Int. Child Health, vol. 32, no. Sup1, pp. 18–21, 2012.

A. Wilder-smith, D. J. Gubler, S. C. Weaver, T. P. Monath, D. L. Heymann, and T. W. Scott, “Epidemic arboviral diseases: priorities for research and public health,” Lancet Infect. Dis., vol. 3099, no. 16, pp. 1–6, 2016.

R. Maciel-de-Freitas, D. Valle, M.-F. Rafael, and V. Denise, “Challenges encountered using standard vector control measures for dengue in Boa Vista, Brazil,” Bull. World Health Organ., vol. 92, no. 9, pp. 685–689, 2014.

S. C. Weaver and W. K. Reisen, “Present and future arboviral threats,” Antiviral Res., vol. 85, no. 2, pp. 328–345, 2010.

L. Braack, A. P. Gouveia De Almeida, A. J. Cornel, R. Swanepoel, and C. De Jager, “Mosquito-borne arboviruses of African origin: Review of key viruses and vectors,” Parasites and Vectors, vol. 11, no. 1, 2018.

C. Isaac and E. J. Agwu, “Mosquito infection with dengue and yellow fever in Bayelsa and Benue States, Nigeria,” Int. J. Infect. Dis., vol. 45, pp. 73–74, 2016.

R. Barrera, “Considerations for disrupting dengue virus transmission; ecology of Aedes aegypti and current (nongenetic) methods of control,” in Genetic Control of Malaria and Dengue, Elsevier Inc., 2016, pp. 103–124.

P. Kittayapong, “Malaria and dengue vector biology and control in Southeast Asia,” in Bridging Laboratory and Field Research for Genetic Control of Disease Vectors, 2007, pp. 111–127.

S. C. Arya and N. Agarwal, “Apropos: An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito,” Parasites and Vectors, vol. 7, no. 1, pp. 1–2, 2014.

J. P. Elder and K. Ballenger-Browning, “Community involvement in dengue vector control,” BMJ, vol. 338, no. b2210, pp. 1453–1455, 2009.

M. F. F. Said, H. Abdullah, and N. Abdul Ghafar, “Dengue prevention practices among community in dengue hotspot area,” Int. J. Community Med. Public Heal., vol. 5, no. 11, p. 4664, 2018.

T. Mariappan, “Dengue transmission,” Environ. Health Perspect., vol. 117, no. 2, pp. 56–57, 2009.

V. Balan, “Meeting the dengue fever challenge,” Biol. Syst. Open Access, vol. 04, no. 01, p. 135, 2015.

A. Wilder-smith, “Dengue infections in travellers,” Paediatr. Int. Child Health, vol. 32, no. Sup 1, pp. 28–32, 2012, doi: 10.1179/2046904712Z.00000000050.

M. Izadi, A. Is’haqi, M. A. Is’haqi, N. J. Jafari, F. Rahamaty, and A. Banki, “An overview of travel-associated central nervous system infectious diseases: risk assessment, general considerations and future directions,” Asian Pac. J. Trop. Biomed., vol. 4, no. 8, pp. 589–596, 2014.

T. W. Scott and A. C. Morrison, “Vector dynamics and dengue prevention,” in Dengue Virus, Current Topics in Microbiology and Immunology, vol. 338, no. 1, A. L. Rothman, Ed. Springer‐Verlag Berlin Heidelberg 2010, 2009, pp. 115–128.

K. T. Wai et al., “Estimating dengue vector abundance in the wet and dry season: implications for targeted vector control in urban and peri-urban Asia,” Pathog. Glob. Health, vol. 106, no. 8, pp. 436–445, 2012.

N. Ibrahim and T. W. Quan, “The development of multi-platforms application for dengue-entomological surveillance system,” IEEE, 2017.

A. M. Marques and M. A. C. Kaplan, “Active metabolites of the genus Piper against Aedes aegypti: Natural alternative sources for dengue vector control,” Univ. Sci., vol. 20, no. 1, pp. 61–82, 2015.

A. R. Ishak, N. C. Dom, H. Hussain, and N. H. Sabri, “Biolarvacidal potential of Ipomoea cairica extracts against key dengue vectors,” Procedia - Soc. Behav. Sci., vol. 153, pp. 180–188, 2014.

H. A. A. Khan and W. Akram, “Citrus-based essential oils could be used for dengue vector mosquitoes control,” Asian Pac. J. Trop. Med., vol. 6, no. 6, p. 504, 2013.

J. Wong, S. T. Stoddard, H. Astete, A. C. Morrison, and T. W. Scott, “Oviposition site selection by the dengue vector Aedes aegypti and its implications for dengue control,” PLoS Negl. Trop. Dis., vol. 5, no. 4, p. e1015, 2011.

M. de B. Arduino, “Assessment of Aedes aegypti pupal productivity during the dengue vector control program in a costal urban centre of São Paulo State, Brazil,” J. Insects, vol. 2014, pp. 1–9, 2014.

F. O. Okumu and S. J. Moore, “Combining indoor residual spraying and insecticide-treated nets for malaria control in Africa: a review of possible outcomes and an outline of suggestions for the future,” Malar. J., vol. 10, no. 208, pp. 1–13, 2011.

K. E. Olson and A. W. E. Franz, “Controlling dengue virus transmission in the field with genetically modified mosquitoes,” in Advances in Human Vector Control, vol. 1014, J. Clark, Ed. Washington DC: American Chemical Society, 2009, pp. 123–141.

L. A. Moreira, “Wolbachia as part of a dengue control strategy – challenge Brazil,” in 2016 XXV International Congress of Entomology, 2016.

A. Watentena and I. C. Okoye, “The untapped potential of mosquito lures for malaria vector surveillance and mass trapping of mosquitoes: a review,” Int. J. Mosq. Res., vol. 6, no. 1, pp. 132–137, 2019.

A. J. Richardson and C. R. Williams, “Inter-population mating success in Australian dengue vector mosquitoes: effects of laboratory colonization and implications for the spread of transgenics,” J. Vector Ecol., vol. 38, no. 1, pp. 111–119, 2013.

A. Mishra and S. Gakkhar, “The effects of awareness and vector control on two strains dengue dynamics,” Appl. Math. Comput., vol. 246, pp. 159–167, 2014.

R. E. Sinden, “The challenge of disrupting vectorial capacity,” in Genetic Control of Malaria and Dengue, Elsevier Inc., 2016, pp. 125–138.

A. H. Azil, S. A. Long, S. A. Ritchie, and C. R. Williams, “The development of predictive tools for pre-emptive dengue vector control: a study of Aedes aegypti abundance and meteorological variables in North Queensland, Australia,” Trop. Med. Int. Heal., vol. 15, no. 10, pp. 1190–1197, 2010.

M. A. McArthu, M. B. Sztein, and R. Edelman, “Prospects for controlling dengue spread: vaccines and vector control,” in Clinical Insights: Dengue: Transmission, Diagnosis & Surveillance, Future Medicine Ltd, 2014, pp. 103–119.

D. M. Khan, “Diagnostic methodologies for the dengue viral infection,” Int. J. Heal. Allied Sci., vol. 5, no. 2, p. 133, 2016.

A. Salem Bin Ghouth, “Dengue in the WHO Eastern Mediterranean Region: challenges to understand its epidemiology,” Heal. Prim. Care, vol. 2, no. 2, pp. 1–2, 2018.

The Lancet, “Dengue challenges India’s health system,” Lancet, vol. 386, no. 10000, p. 1212, 2015.

J. Beauté and S. Vong, “Cost and disease burden of Dengue in Cambodia,” BMC Public Health, vol. 10, no. 1, pp. 2–7, 2010, doi: 10.1186/1471-2458-10-521.

A. Badolo et al., “Third Tofo advanced study week on emerging and re-emerging viruses, 2018,” Antiviral Res., vol. 162, pp. 142–150, 2019.

K. K. Ariën and A. Wilder-Smith, “Dengue vaccine: reliably determining previous exposure,” Lancet Glob. Heal., vol. 6, no. 8, pp. e830–e831, 2018.

M. Recker, K. Vannice, J. Hombach, M. Jit, and C. P. Simmons, “Assessing dengue vaccination impact: model challenges and future directions,” Vaccine, vol. 34, no. 38, pp. 4461–4465, 2016.

M. L. Robinson and A. P. Durbin, “Dengue vaccines: implications for dengue control,” Curr. Opin. Infect. Dis., vol. 30, no. 5, pp. 449–454, 2017.

S. Polwiang, “The effectiveness of dengue vaccine and vector control: Model study,” KMUTNB Int. J. Appl. Sci. Technol., vol. 11, no. 3, pp. 225–232, 2018.

G. N. Lucas, “A fresh look at dengue vaccines,” Sri Lanka Journalof Child Heal., vol. 45, no. 3, pp. 149–150, 2016.

A. P. Durbin and S. S. Whitehead, “The dengue human challenge model: has the time come to accept this challenge?,” J. Infect. Dis., vol. 207, no. 5, pp. 697–699, 2013.

R. C. Christofferson and C. N. Mores, “A role for vector control in dengue vaccine programs,” Vaccine, vol. 33, no. 50, pp. 7069–7074, 2015.

M. S. Diamond, E. Harris, and F. A. Ennis, “Defeating dengue: a challenge for a vaccine,” Nat. Med., vol. 18, no. 11, pp. 1622–1623, 2012.

R. W. S. Hendron and M. B. Bonsall, “The interplay of vaccination and vector control on small dengue networks,” J. Theor. Biol., vol. 407, pp. 349–361, 2016.

Global Malaria Programme, “Tailoring malaria interventions in the COVID-19 response,” World Health Organization, Geneva, 2020.

DW Television, “The coronavirus spreads at a fractic pace between Tijuana and Tierra del Fuego,” Latin America, 2020.